NIOX Stock Overview
Engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for NIOX from our risk checks.
My Notes
Capture your thoughts, links and company narrative
NIOX Group Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.62 |
| 52 Week High | UK£0.80 |
| 52 Week Low | UK£0.57 |
| Beta | 0.96 |
| 1 Month Change | -5.20% |
| 3 Month Change | -4.91% |
| 1 Year Change | -5.20% |
| 3 Year Change | 51.96% |
| 5 Year Change | 220.00% |
| Change since IPO | -80.00% |
Recent News & Updates
Recent updates
What NIOX Group Plc's (LON:NIOX) P/E Is Not Telling You
Jul 25
NIOX Group's (LON:NIOX) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 05Are Investors Undervaluing NIOX Group Plc (LON:NIOX) By 28%?
May 17We Think Shareholders Should Be Aware Of Some Factors Beyond NIOX Group's (LON:NIOX) Profit
Apr 03We're Interested To See How Circassia Group (LON:CIR) Uses Its Cash Hoard To Grow
Jan 05Here's What Circassia Group Plc's (LON:CIR) Shareholder Ownership Structure Looks Like
Mar 13Have Insiders Been Buying Circassia Group Plc (LON:CIR) Shares This Year?
Feb 04Shareholder Returns
| NIOX | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 1.0% | -2.0% | -1.4% |
| 1Y | -5.2% | -7.9% | 4.6% |
Return vs Industry: NIOX exceeded the UK Medical Equipment industry which returned -7.9% over the past year.
Return vs Market: NIOX underperformed the UK Market which returned 4.6% over the past year.
Price Volatility
| NIOX volatility | |
|---|---|
| NIOX Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: NIOX has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: NIOX's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 92 | n/a | investors.niox.com |
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.
NIOX Group Plc Fundamentals Summary
| NIOX fundamental statistics | |
|---|---|
| Market cap | UK£244.36m |
| Earnings (TTM) | UK£11.00m |
| Revenue (TTM) | UK£39.00m |
22.4x
P/E Ratio6.3x
P/S RatioIs NIOX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIOX income statement (TTM) | |
|---|---|
| Revenue | UK£39.00m |
| Cost of Revenue | UK£11.00m |
| Gross Profit | UK£28.00m |
| Other Expenses | UK£17.00m |
| Earnings | UK£11.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Apr 01, 2025
| Earnings per share (EPS) | 0.028 |
| Gross Margin | 71.79% |
| Net Profit Margin | 28.21% |
| Debt/Equity Ratio | 0% |
How did NIOX perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield38%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 21:03 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NIOX Group Plc is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Julie Simmonds | Canaccord Genuity |
| Jens Lindqvist | Investec Bank plc (UK) |
| Richard Vosser | J.P. Morgan |